{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T09:58:13Z","timestamp":1792058293984,"version":"4.4.0"},"reference-count":30,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":["www.ahajournals.org"],"crossmark-restriction":true},"short-container-title":["Circ: Cardiovascular Quality and Outcomes"],"published-print":{"date-parts":[[2009,3]]},"abstract":"<jats:p>\n            <jats:bold>\n              <jats:italic>Background\u2014<\/jats:italic>\n            <\/jats:bold>\n            Influenza infection has been associated with increased risk of adverse cardiac and cerebral vascular outcomes. Oseltamivir, a treatment for influenza, has been shown to decrease the severity of an influenza episode, but few data exist regarding its potentially protective effect against recurrent vascular outcomes among influenza patients with a history of vascular disease.\n          <\/jats:p>\n          <jats:p>\n            <jats:bold>\n              <jats:italic>Methods and Results\u2014<\/jats:italic>\n            <\/jats:bold>\n            Electronic healthcare service and pharmacy records for 37 482 TRICARE beneficiaries, aged 18 and older, with a coded history of cardiovascular (CV) disease and a subsequent diagnosis of influenza from October 1, 2003, through September 30, 2007, were examined. Subjects were grouped according to whether they had filled a prescription for oseltamivir within 2 days of their influenza diagnosis. The incidence of recurrent CV events within 30 days after the influenza diagnosis among oseltavmivir-treated and untreated subjects was 8.5% and 21.2%, respectively (\n            <jats:italic>P<\/jats:italic>\n            &lt;0.005). Subject age was a persistent and significant contributor to the likelihood of recurrent CV outcomes. After controlling for the differences in demographics among treated and untreated cohorts using a propensity-scored logistic regression model, a statistically significant protective effect was associated with oseltamivir treatment (odds ratio, 0.417; 95% CI, 0.349 to 0.498).\n          <\/jats:p>\n          <jats:p>\n            <jats:bold>\n              <jats:italic>Conclusions\u2014<\/jats:italic>\n            <\/jats:bold>\n            Our findings suggests that oseltamivir treatment for influenza is associated with significant decrease in the risk of recurrent CV events in subjects with a history of CV disease. These findings merit confirmation in further prospective and controlled studies. Meanwhile, in patients with CV disease, strict adherence with current practice guidelines for prevention and treatment of influenza is recommended.\n          <\/jats:p>","DOI":"10.1161\/circoutcomes.108.820357","type":"journal-article","created":{"date-parts":[[2009,3,6]],"date-time":"2009-03-06T05:21:37Z","timestamp":1236316897000},"page":"108-115","update-policy":"https:\/\/doi.org\/10.1161\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":47,"title":["Use of Oseltamivir After Influenza Infection Is Associated With Reduced Incidence of Recurrent Adverse Cardiovascular Outcomes Among Military Health System Beneficiaries With Prior Cardiovascular Diseases"],"prefix":"10.1161","volume":"2","author":[{"given":"S. Ward","family":"Casscells","sequence":"first","affiliation":[{"name":"From Health Affairs (S.W.C.), TRICARE Management Activity (E.G.), and Health Program Analysis and Evaluation (A.M.K., A.L., L.C.), West Falls Church, Va; and Texas Heart Institute and Baylor College of Medicine (M.M.), Houston, Tex."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elder","family":"Granger","sequence":"additional","affiliation":[{"name":"From Health Affairs (S.W.C.), TRICARE Management Activity (E.G.), and Health Program Analysis and Evaluation (A.M.K., A.L., L.C.), West Falls Church, Va; and Texas Heart Institute and Baylor College of Medicine (M.M.), Houston, Tex."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amii M.","family":"Kress","sequence":"additional","affiliation":[{"name":"From Health Affairs (S.W.C.), TRICARE Management Activity (E.G.), and Health Program Analysis and Evaluation (A.M.K., A.L., L.C.), West Falls Church, Va; and Texas Heart Institute and Baylor College of Medicine (M.M.), Houston, Tex."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Linton","sequence":"additional","affiliation":[{"name":"From Health Affairs (S.W.C.), TRICARE Management Activity (E.G.), and Health Program Analysis and Evaluation (A.M.K., A.L., L.C.), West Falls Church, Va; and Texas Heart Institute and Baylor College of Medicine (M.M.), Houston, Tex."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Madjid","sequence":"additional","affiliation":[{"name":"From Health Affairs (S.W.C.), TRICARE Management Activity (E.G.), and Health Program Analysis and Evaluation (A.M.K., A.L., L.C.), West Falls Church, Va; and Texas Heart Institute and Baylor College of Medicine (M.M.), Houston, Tex."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda","family":"Cottrell","sequence":"additional","affiliation":[{"name":"From Health Affairs (S.W.C.), TRICARE Management Activity (E.G.), and Health Program Analysis and Evaluation (A.M.K., A.L., L.C.), West Falls Church, Va; and Texas Heart Institute and Baylor College of Medicine (M.M.), Houston, Tex."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"e_1_3_2_1_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(97)11084-4"},{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa041747"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehm035"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.aje.a112007"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.aje.a113063"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(04)17176-6"},{"key":"e_1_3_2_7_2","first-page":"1","volume":"56","year":"2007","unstructured":"Fiore AE, Shay DK, Haber P, Iskander JK, Uyeki TM, Mootrey G, Bresee JS, Cox NJ; Advisory Committee on Immunization Practices (ACIP), Centers for Disease Control and Prevention (CDC). Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2007. MMWR Recomm Rep. 2007; 56 (RR-6): 1\u201354.Available at: http:\/\/www.medscape.com\/medline\/abstract\/11334444?src=emed_ckb_ref_0. Accessed March 28, 2008.","journal-title":"MMWR Recomm Rep"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2006.04.026"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa025028"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1161\/circ.102.25.3039"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.str.0000170674.45136.80"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.cir.0000102380.47012.92"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.2165\/00044011-200323090-00002"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1345\/aph.1H174"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra050740"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1185\/030079907X242520"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2007.10.001"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1002\/pds.845"},{"key":"e_1_3_2_19_2","first-page":"23.","volume":"9","year":"2007","unstructured":"Blumentals WA, Song X. The safety of oseltamivir in patients from influenza: analysis of healthcare claims from six influenza seasons. MedGenMed. 2007; 9: 23. Available at: http:\/\/www.pubmedcentral.nih.gov\/articlerender.fcgi?tool=pubmed&pubmedid=18311373. Accessed March 3, 2008.","journal-title":"MedGenMed"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1177\/135965350400900217"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.326.7401.1235"},{"key":"e_1_3_2_22_2","unstructured":"Leslie S Thiebaud P. Using Propensity Scores to Adjust For Treatment Selection Bias. Proceedings of the SAS\ufffd Global Forum 2007 Conference. Cary NC: SAS Institute Inc; 2007. Available at: http:\/\/www2.sas.com\/proceedings\/forum2007\/184\u20132007.pdf. Accessed December 1 2008."},{"key":"e_1_3_2_23_2","unstructured":"Bowles SK Lee W Simor AE Vearncombe M Loeb M Tamblyn S Fearon M McGeer A; Oseltamivir Compassionate Use Program Group. Use of eseltamivir during influenza outbreaks in Ontario nursing homes 1999\u20132000. Cardiovascular Disease Statistics. \ufffd 2008 American Heart Association Inc. Available at: http:\/\/www.americanheart.org\/ presenter.jhtml?identifier=4478. Accessed May 29 2008."},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-139-5_Part_1-200309020-00007"},{"key":"e_1_3_2_25_2","first-page":"4","volume":"31","year":"2004","unstructured":"Madjid M, Aboshady I, Awan I, Litovsky S, Casscells SW. Influenza and cardiovascular disease: is there a causal relationship? Tex Heart Inst J. 2004; 31: 4\u201313.","journal-title":"Tex Heart Inst J"},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.1086\/518849"},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2006.09.004"},{"key":"e_1_3_2_28_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.0730-7659.2004.0268.x"},{"key":"e_1_3_2_29_2","unstructured":"United States Department of Health and Human Services. HHS Pandemic Influenza Plan Supplement 7 Antiviral Drug Distribution and Use. Available at: http:\/\/www.hhs.gov\/pandemicflu\/plan\/sup7.html. Accessed March 14 2007."},{"key":"e_1_3_2_30_2","doi-asserted-by":"publisher","DOI":"10.1289\/ehp.9574"}],"container-title":["Circulation: Cardiovascular Quality and Outcomes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ahajournals.org\/doi\/full\/10.1161\/CIRCOUTCOMES.108.820357","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,13]],"date-time":"2024-05-13T02:32:13Z","timestamp":1715567533000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ahajournals.org\/doi\/10.1161\/CIRCOUTCOMES.108.820357"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,3]]},"references-count":30,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2009,3]]}},"alternative-id":["10.1161\/CIRCOUTCOMES.108.820357"],"URL":"https:\/\/doi.org\/10.1161\/circoutcomes.108.820357","relation":{},"ISSN":["1941-7713","1941-7705"],"issn-type":[{"value":"1941-7713","type":"print"},{"value":"1941-7705","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,3]]},"assertion":[{"value":"2009-03-01","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}